Last weekend, members of the Plus Therapeutics and CNSide Diagnostics teams, led by Gabby Cleveland, participated in the 7th Annual Head for the Cure Foundation 5K in Phoenix, Arizona — running and walking in support of brain cancer research and awareness.

This event unites patients, caregivers, and advocates from across the community, raising funds to support local and national brain tumor programs that bring hope, research, and education to those impacted by the disease.

Proceeds from the Phoenix 5K directly benefit:

• Ivy Brain Tumor Center at Barrow Neurological Institute — advancing early-phase clinical trials for brain tumors.
• Brains for the Cure — providing education and emotional support for patients and families navigating brain cancer.
• Other national brain tumor research and advocacy initiatives driving progress in patient outcomes.

Why It Matters

At Plus Therapeutics and CNSide Diagnostics, we’re united by a mission to advance innovation in neuro-oncology — from targeted radiotherapeutics like REYOBIQ™ to precision CSF diagnostics that detect and monitor tumor cells in the central nervous system (CNS).

Community-driven events like Head for the Cure remind us that breakthroughs in science are only possible through collaboration — between researchers, physicians, patients, and advocates — working together to make every step count.

We’re grateful to our team and all who joined us in support of this important cause.

Learn More

About Head for the Cure Foundation: https://headforthecure.org/
About CNSide Diagnostics: https://cnside-dx.com
About Plus Therapeutics’ CNS oncology research: https://plustherapeutics.com/radiotherapeutics